Cargando…
IL-17 and IL-23 levels in patients with early-stage chronic lymphocytic leukemia
OBJECTIVE: Cytokines produced by bone marrow mesenchymal stem cells are important components of the tumor microenvironment in chronic lymphocytic leukemia (CLL). The roles of IL-17 and IL-23 in both autoimmune diseases and tumor growth have been demonstrated. The role of the IL-17/23 axis in apoptos...
Autores principales: | Bankir, Mehmet, Acik, Didar Yanardag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881423/ https://www.ncbi.nlm.nih.gov/pubmed/33623869 http://dx.doi.org/10.14744/nci.2020.02997 |
Ejemplares similares
-
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
por: Acik, Didar Yanardag, et al.
Publicado: (2019) -
Relationship of SARS-CoV-2 Pandemic with Blood Groups
por: Yanardag Acik, Didar, et al.
Publicado: (2021) -
Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis
por: Bilik, Mehmet Zihni, et al.
Publicado: (2016) -
Recognizing the unusual findings: Cases of desiderosmia
por: Yanardag Acik, Didar
Publicado: (2019) -
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
por: Navarro-Compán, Victoria, et al.
Publicado: (2023)